Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 2, 1996, Pages 245-248

  Sanderson, H M ^a   Heptinstall, S ^a   Vickers, J ^b   Losche W ^b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Aggregation; ARL 66096; Flow cytometry; Platelet; Shape change

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 [4 [4 (AMINOIMINOMETHYL)PHENYL] 1 PIPERAZINYL] 1 PIPERIDINEACETIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; APAFANT; ARL 66096; CALCIMYCIN; COLLAGEN; GR 159897; SARPOGRELATE; SEROTONIN; SULOTROBAN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE SHAPE;

EID: 0029905319     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199603000-00034     Document Type: Conference Paper

References (10)

1. Frojmovic MM, Milton JG. Human platelet size, shape, and related functions in health and disease. Physiol Rev 1982; 62: 185-261.
2. Zucker MB, Troll W, Belman S. The tumour promoter phorbol ester (12-O-tetradecanoyl-phorbol-13-acetate), a potent aggregating agent for blood platelets. J Cell Biol 1974; 60: 325-336.
3. Ruf A, Patscheke H. Flow cytometric measurement of the platelet shape change. Thromb Haemost 1993; 69: 702.
4. Heptinstall S, Sanderson HM. A flow cytometric investigation of platelet shape change in whole blood. Evidence that the shape change and aggregation induced by ADP are mediated by different receptors. Platelets 1995; 6: 52-53.
5. Ruf A, Patscheke H. Flow cytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and P-selectin expression. Sem Thromb Haemost 1995; 21: 146-151.
6. Fox SC, Burgess-Wilson M, Heptinstall S, Mitchell JRA. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Whole Blood Platelet Counter. Thromb Haemostas 1982; 48: 327-329.
7. Armstrong R, May JA, Lösche W, Heptinstall S. Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood. Thromb Haemost 1995; 73: 297-303.
8. 2T-purinoceptors. Br J Pharmacol 1994; 113: 1057-1063.
9. 2T-purinoceptor antagonist, FLP 67085, reliably, reversibly and safely inhibits ADP-induced platelet aggregation ex vivo in man. Br J Clin Pharmacol 1995; 39: 98P.
10. Cachet C, Cattaneo M, Ohlmann P, et al. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol 1995; 91: 434-444.